Skip to main content

Berta Saez Gimenez

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Berta Saez Gimenez

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca

Projects

Enfermedad tromboembólica tras el trasplante pulmonar

IP: Antonio Román Broto
Collaborators: Berta Saez Gimenez
Funding agency: Fundació Institut de Recerca HUVH
Funding: 46800
Reference: PRED-VHIR-2015-28
Duration: 01/03/2016 - 28/02/2019

Estudio de descubrimiento y validación de potenciales biomarcadores de tolerancia en supervivientes a largo plazo después de un trasplante pulmonar (estudio TOLUNG).

IP: -
Collaborators: Cristina Berastegui Garcia, Susana Gómez Olles, Berta Saez Gimenez
Funding agency: Fundació Catalana de Pneumologia
Funding: 14000
Reference: 2014\FUCAP-BAA_ROMAN
Duration: 01/06/2014 - 31/05/2017

Pneumologia (GRC)

IP: Ferran Morell Brotad
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Sonia Lopez Rodriguez, Montserrat Murillo Andres, Miriam Barrecheguren Fernández, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Marta Castro D la Visitación, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Maria Antonia Ramon Belmonte, Rosa Lloria Verges, Oriol Roca Gas, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Manuel López Meseguer, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 523
Duration: 01/01/2014 - 31/12/2016

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Vicente Serra García

Vicente Serra García

Cardiovascular Diseases
Read more
Rocío Garcia Risco

Rocío Garcia Risco

Read more
Montse Arroyo Barreras

Montse Arroyo Barreras

Administrative
Accounting and Revenue Unit
Finances Area
Read more
Jorge Daniel Fernández Núñez

Jorge Daniel Fernández Núñez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.